What is Semaglutide?

Semaglutide injections are a type of medication used to treat type 2 diabetes. They work by mimicking the effects of a hormone called GLP-1, which helps regulate blood sugar levels. Semaglutide injections are usually given once a week and can be used on their own or in combination with other diabetes medications.

Semaglutide injections are also approved for weight loss. The medication is marketed specifically for weight management under the brand name Wegovy. In June of 2021, the U.S. FDA has approved Wegovy (semaglutide) injection for chronic weight management in adults who are obese or overweight and have at least one weight-related condition. The injection is given once a week and must be be administered in addition to a eating a healthy balanced diet and regular exercise. Having the injection ins't enough, patients must still focus on a balnced diet and exercise.

How are semaglutide injections used for weightloss?

For weight loss, semaglutide injections are typically administered once a week, and the dose is gradually increased over a period of several weeks. The medication works by reducing appetite, increasing feelings of fullness, and slowing down the rate at which food moves through the stomach.

Semaglutide promotes weight loss by increasing insulin production and decreasing glucagon production, resulting in reduced appetite and increased energy levels.

Semaglutide injections for weight loss are only approved for use in adults with a body mass index (BMI) of 30 or higher, or in adults with a BMI of 27 or higher who also have at least one weight-related health condition, such as high blood pressure or type 2 diabetes.

Are semaglutide injections safe?

Weight loss services and aesthetics are generally considered safe when they are performed by a qualified healthcare professional and when proper post-care instructions are followed. However, as with any medical procedure, there are risks and potential side effects. Your healthcare provider will discuss these with you and provide instructions for minimizing the risk of complications.

The most common side effects of Wegovy are nausea, diarrhea, vomiting, constipation, stomach pain, headache, fatigue, indigestion, dizziness, bloating, belching, low blood sugar in patients with type 2 diabetes, gas buildup, intestinal infection, and digestive disorder as per the FDA Press Release regarding its approval for use in weight loss treatments.

How much weight can you lose with semaglutide injections?

In a study done in 2022, patients recieving 2.4mg of semaglutide lost a mean of 6% of their body weight within 12 weeks, and by week 28 they had lost 12% of their body weight.

Book A Consultation